Gene Ward of Thaxton, left, was the first patient enrolled in a clinical trial for a new procedure called radiofrequency septal ablation developed by local cardiac electrophysiologist Karl Crossen, M.D. The procedure treats hypertrophic obstructive cardiomyopathy (HOCM), a genetic disease where the hearts septum is enlarged or thickened. (NMMC)